| November 1, 2016 | | |  | | | | | | Talk to your doctor about new drug treatments | | For patients with moderate to severe disease, which affects large areas of skin or even smaller areas that are crucial to daily living (such as hands, feet or genitalia), therapy may include oral drugs and biologic agents (given by injection or infusion). The latter drugs work by targeting certain chemical messengers in the immune system, such as interleukin-17, which promotes inflammation. One drug that's being called the next breakthrough drug is called secukinumab, which blocks this inflammation chemical messenger. Research continues the quest for even better treatments that boast higher efficacy rates and fewer adverse effects. Read more: | | | | FOLLOW US ON SOCIAL NETWORKS | | | SIGN UP FOR OUR OTHER NEWSLETTERS | | | | |  | | | |  |           | If you would like to subscribe to our other newsletters, please click here.
© 2016 Reader's Digest Magazines Canada Limited, 1100 boul. René-Lévesque W., Montréal, Québec H3B 5H5
You have received this e-mail because you are a friend of Reader's Digest Canada. We hope you have enjoyed receiving it. However, if you would rather not receive future messages of this sort from us, simply click on the following link: click here to unsubscribe.
Privacy Policy | Contact us | | | |
No comments:
Post a Comment